ArticleEcoHealth2026
First Pandemic blaCTX-M-8-Producing ST224 E. coli in Brazilian Sheep: Resistance and Genomic Traits.
Article in EcoHealth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Wildlife-Livestock Interface as a Bidirectional Pathway for the Spread of ESBL-ProducingAnimals : an open access journal from MDPI · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shiga toxin-producing E. coli (STEC) strains are particularly concerning due to their zoonotic potential and environmental persistence. Ruminants, especially sheep and cattle, serve as primary reservoirs, often shedding pathogenic strains asymptomatically and contributing to foodborne outbreaks through contamination of animal-derived products. This study aimed to characterize antimicrobial-resistant E. coli strains isolated from dairy sheep in Brazil, focusing on phylogenetic backgrounds, resistance profiles, and genomic features. From 65 rectal swab samples collected across five herds in two Brazilian states, 65 E. coli isolates were recovered. Of these, 27.7% showed antimicrobial resistance to at least one drug tested, and 32.3% were identified as STEC. Resistance was most frequently observed against sulfamethoxazole-trimethoprim, tetracycline, and gentamicin. Notably, one isolate (LZB-RS-110) exhibited an extended-spectrum β-lactamase (ESBL) phenotype and a multidrug-resistant profile. Whole-genome sequencing identified clinically relevant resistance genes (e.g., bla
Indexed as
Identifiers
41175318What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.